Novocure (NVCR) Misses Q1 EPS by 13c, provides guidance

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.62), $0.13 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $174.1 million versus the consensus estimate of $167.77 million.

GUIDANCE:

Novocure sees FY2026 revenue of $690-710 million, versus the consensus of $694.7 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'
• Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight